Document is current
Any future updates will be listed below
-
Authors
Wentzel, Annemarie
Duhuze Karera, M. Grace
Patterson, Arielle C.
Waldman, Zoe C.
Schenk, Blayne R.
Mabundo, Lilian S.
DuBose, Christopher W.
Horlyck-Romanovsky, Margrethe F.
Sumner, Anne E.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct00001853 at ClinicalTrials.govDocuments that mention this clinical trial
Metabolic characteristics of Africans with normal glucose tolerance and elevated 1-hour glucose: insight from the Africans in America study
https://doi.org/10.1136/bmjdrc-2019-000837
The Africans in America study demonstrates that subclinical cardiovascular risk differs by etiology of abnormal glucose tolerance
https://doi.org/10.1038/s41598-022-19917-8
Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America study
https://doi.org/10.1136/bmjdrc-2021-002447
Improved Detection of Abnormal Glucose Tolerance in Africans: The Value of Combining Hemoglobin A1c With Glycated Albumin (Results)
https://doi.org/10.2337/dc20-1119
Do current guidelines for waist circumference apply to black Africans? Prediction of insulin resistance by waist circumference among Africans living in America
https://doi.org/10.1136/bmjgh-2018-001057
-
Funding
Funding for this research was provided by:
North-West University
- License Information
-
More Information
Article History
Received: 22 June 2022
Accepted: 6 September 2022
First Online: 10 October 2022
Competing interests
: The authors declare no competing interests.
